Onderneming Renovaro Inc. Börse Stuttgart
Aandelen
2Q5
US29350E1047
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,362 EUR | +3,18% | +6,24% | -56,62% |
Vakgebied
Aantal werknemers: 12
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mark Dybul
CEO | Chief Executive Officer | 60 | 23-01-18 |
Lester Russell
CTO | Chief Tech/Sci/R&D Officer | - | 21-08-23 |
Greg Duczynski
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-16 |
Joseph R. Cohen
CTO | Chief Tech/Sci/R&D Officer | - | - |
François Binette
COO | Chief Operating Officer | - | 20-04-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gregg Alton
BRD | Director/Board Member | 58 | 01-01-20 |
Avram Miller
BRD | Director/Board Member | - | 11-10-23 |
James Sapirstein
BRD | Director/Board Member | 63 | 06-03-18 |
Director/Board Member | 60 | 04-10-23 | |
Director/Board Member | 78 | 04-10-23 | |
Carol Brosgart
BRD | Director/Board Member | 72 | 27-12-19 |
Rene Sindlev
CHM | Chairman | 61 | 18-01-11 |
Mark Dybul
CEO | Chief Executive Officer | 60 | 23-01-18 |
Jayne McNicol
BRD | Director/Board Member | 57 | 25-05-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 147 504 944 | 109 814 931 ( 74,45 %) | 0 | 74,45 % |
Aandeel B | 0 | 561 010 | 0 | 0 |
Bedrijfsgegevens
Renovaro, Inc.
1927 Paseo Rancho Castillo
90032-2012, Los Angeles
+45 39 17 98 40
http://www.enochianbio.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,91% | 118 mld. | |
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,82% | 21,96 mld. | |
-10,12% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. |
- Beurs
- Aandelen
- Koers RENB
- Koers 2Q5
- Onderneming Renovaro Inc.